Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 2 |
NetGPI | no | yes: 0, no: 2 |
Related structures:
AlphaFold database: E9AQS2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 169 | 173 | PF00656 | 0.563 |
CLV_NRD_NRD_1 | 156 | 158 | PF00675 | 0.407 |
CLV_NRD_NRD_1 | 160 | 162 | PF00675 | 0.412 |
CLV_NRD_NRD_1 | 93 | 95 | PF00675 | 0.518 |
CLV_PCSK_FUR_1 | 157 | 161 | PF00082 | 0.427 |
CLV_PCSK_KEX2_1 | 156 | 158 | PF00082 | 0.407 |
CLV_PCSK_KEX2_1 | 159 | 161 | PF00082 | 0.430 |
CLV_PCSK_KEX2_1 | 210 | 212 | PF00082 | 0.437 |
CLV_PCSK_KEX2_1 | 93 | 95 | PF00082 | 0.595 |
CLV_PCSK_PC1ET2_1 | 159 | 161 | PF00082 | 0.450 |
CLV_PCSK_PC1ET2_1 | 210 | 212 | PF00082 | 0.437 |
CLV_PCSK_PC7_1 | 156 | 162 | PF00082 | 0.427 |
CLV_PCSK_SKI1_1 | 156 | 160 | PF00082 | 0.553 |
CLV_PCSK_SKI1_1 | 197 | 201 | PF00082 | 0.403 |
CLV_PCSK_SKI1_1 | 34 | 38 | PF00082 | 0.508 |
DOC_ANK_TNKS_1 | 71 | 78 | PF00023 | 0.527 |
DOC_CYCLIN_yCln2_LP_2 | 223 | 229 | PF00134 | 0.513 |
DOC_MAPK_DCC_7 | 78 | 86 | PF00069 | 0.519 |
DOC_MAPK_gen_1 | 18 | 26 | PF00069 | 0.504 |
DOC_MAPK_MEF2A_6 | 20 | 28 | PF00069 | 0.514 |
DOC_MAPK_MEF2A_6 | 78 | 86 | PF00069 | 0.519 |
DOC_PP2B_LxvP_1 | 199 | 202 | PF13499 | 0.392 |
DOC_PP2B_LxvP_1 | 223 | 226 | PF13499 | 0.523 |
DOC_PP2B_LxvP_1 | 37 | 40 | PF13499 | 0.572 |
DOC_PP2B_LxvP_1 | 43 | 46 | PF13499 | 0.555 |
DOC_PP2B_LxvP_1 | 82 | 85 | PF13499 | 0.525 |
DOC_USP7_MATH_1 | 164 | 168 | PF00917 | 0.499 |
DOC_USP7_MATH_1 | 178 | 182 | PF00917 | 0.492 |
DOC_USP7_MATH_2 | 226 | 232 | PF00917 | 0.490 |
DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.492 |
DOC_WW_Pin1_4 | 35 | 40 | PF00397 | 0.504 |
DOC_WW_Pin1_4 | 63 | 68 | PF00397 | 0.499 |
LIG_14-3-3_CanoR_1 | 18 | 28 | PF00244 | 0.584 |
LIG_14-3-3_CanoR_1 | 62 | 67 | PF00244 | 0.488 |
LIG_BIR_III_4 | 185 | 189 | PF00653 | 0.489 |
LIG_BRCT_BRCA1_1 | 125 | 129 | PF00533 | 0.394 |
LIG_CtBP_PxDLS_1 | 25 | 29 | PF00389 | 0.495 |
LIG_eIF4E_1 | 149 | 155 | PF01652 | 0.384 |
LIG_EVH1_1 | 43 | 47 | PF00568 | 0.486 |
LIG_FHA_1 | 190 | 196 | PF00498 | 0.455 |
LIG_FHA_1 | 212 | 218 | PF00498 | 0.646 |
LIG_FHA_1 | 27 | 33 | PF00498 | 0.515 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.518 |
LIG_FHA_2 | 169 | 175 | PF00498 | 0.561 |
LIG_LIR_Gen_1 | 126 | 137 | PF02991 | 0.383 |
LIG_LIR_LC3C_4 | 65 | 70 | PF02991 | 0.511 |
LIG_LIR_Nem_3 | 126 | 132 | PF02991 | 0.382 |
LIG_LIR_Nem_3 | 174 | 179 | PF02991 | 0.638 |
LIG_LIR_Nem_3 | 218 | 223 | PF02991 | 0.514 |
LIG_Pex14_1 | 220 | 224 | PF04695 | 0.521 |
LIG_Pex14_2 | 129 | 133 | PF04695 | 0.369 |
LIG_SH2_NCK_1 | 3 | 7 | PF00017 | 0.486 |
LIG_SH2_NCK_1 | 54 | 58 | PF00017 | 0.539 |
LIG_SH2_SRC | 224 | 227 | PF00017 | 0.519 |
LIG_SH2_SRC | 54 | 57 | PF00017 | 0.553 |
LIG_SH2_STAT5 | 134 | 137 | PF00017 | 0.391 |
LIG_SH2_STAT5 | 224 | 227 | PF00017 | 0.519 |
LIG_SH3_1 | 3 | 9 | PF00018 | 0.477 |
LIG_SH3_3 | 139 | 145 | PF00018 | 0.468 |
LIG_SH3_3 | 3 | 9 | PF00018 | 0.477 |
LIG_SH3_3 | 36 | 42 | PF00018 | 0.509 |
LIG_SUMO_SIM_par_1 | 24 | 29 | PF11976 | 0.497 |
LIG_SUMO_SIM_par_1 | 46 | 52 | PF11976 | 0.502 |
LIG_TYR_ITIM | 132 | 137 | PF00017 | 0.380 |
LIG_WW_2 | 41 | 44 | PF00397 | 0.478 |
MOD_CK1_1 | 96 | 102 | PF00069 | 0.680 |
MOD_CK2_1 | 100 | 106 | PF00069 | 0.646 |
MOD_GlcNHglycan | 102 | 105 | PF01048 | 0.585 |
MOD_GlcNHglycan | 111 | 114 | PF01048 | 0.589 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.551 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.451 |
MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.518 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.664 |
MOD_GlcNHglycan | 95 | 98 | PF01048 | 0.592 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.530 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.458 |
MOD_GSK3_1 | 211 | 218 | PF00069 | 0.463 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.581 |
MOD_GSK3_1 | 93 | 100 | PF00069 | 0.623 |
MOD_LATS_1 | 60 | 66 | PF00433 | 0.481 |
MOD_LATS_1 | 91 | 97 | PF00433 | 0.599 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.589 |
MOD_NEK2_1 | 26 | 31 | PF00069 | 0.501 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.598 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.554 |
MOD_OFUCOSY | 135 | 140 | PF10250 | 0.411 |
MOD_OFUCOSY | 16 | 23 | PF10250 | 0.512 |
MOD_PKA_1 | 93 | 99 | PF00069 | 0.601 |
MOD_PKA_2 | 19 | 25 | PF00069 | 0.571 |
MOD_PKA_2 | 93 | 99 | PF00069 | 0.601 |
MOD_Plk_1 | 123 | 129 | PF00069 | 0.389 |
MOD_Plk_1 | 212 | 218 | PF00069 | 0.656 |
MOD_Plk_4 | 128 | 134 | PF00069 | 0.427 |
MOD_Plk_4 | 150 | 156 | PF00069 | 0.471 |
MOD_Plk_4 | 49 | 55 | PF00069 | 0.647 |
MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.488 |
MOD_ProDKin_1 | 35 | 41 | PF00069 | 0.500 |
MOD_ProDKin_1 | 63 | 69 | PF00069 | 0.501 |
TRG_DiLeu_BaLyEn_6 | 218 | 223 | PF01217 | 0.514 |
TRG_ENDOCYTIC_2 | 134 | 137 | PF00928 | 0.391 |
TRG_ENDOCYTIC_2 | 149 | 152 | PF00928 | 0.293 |
TRG_ER_diArg_1 | 155 | 157 | PF00400 | 0.405 |
TRG_ER_diArg_1 | 160 | 162 | PF00400 | 0.405 |
TRG_ER_diArg_1 | 92 | 94 | PF00400 | 0.597 |
TRG_NLS_MonoExtN_4 | 156 | 163 | PF00514 | 0.435 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
Q4QEQ5 | Leishmania major | 81% | 91% |